Saturday, April 20, 2024

Saturday, April 20, 2024

Organization Directory

Refine Your Search 0

Type:

Filter by Org Type:

Filter By Name:


Trending

  1. 1 ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients
FDA Reporter